4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+))
C128H98F3N16OPt4-3 — CID 158024918
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+))
4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+)) (PubChem CID 158024918) has the molecular formula C128H98F3N16OPt4-3 and a molecular weight of 2713.61 g/mol. Its IUPAC name is 4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+)).
Molecular Properties
| Compound Name | 4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+)) |
|---|---|
| PubChem CID | 158024918 |
| Molecular Formula | C128H98F3N16OPt4-3 |
| Molecular Weight | 2713.61 g/mol |
| Exact Mass | 2711.67 |
| IUPAC Name | 4-dibenzofuran-3-yl-1-phenylpyrazole;bis(1,4-dimethyl-3-phenyl-5-(4-phenylphenyl)-2H-imidazol-2-ide);3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;bis(3-methyl-5-phenylpyrazol-1-ide);2-phenylimidazol-3-ide;5-phenyl-3-(trifluoromethyl)pyrazol-1-ide;platinum;tris(platinum(4+)) |
| SMILES | CC1=C(c2ccc(-c3ccccc3)cc2)N(C)[CH-]N1c1[c-]cccc1.CC1=C(c2ccc(-c3ccccc3)cc2)N(C)[CH-]N1c1[c-]cccc1.CN1[CH-]N(c2[c-]cccc2)C=C1c1ccc(-c2ccccc2)cc1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.FC(F)(F)c1cc(-c2[c-]cccc2)[n-]n1.[Pt+4].[Pt+4].[Pt+4].[Pt].[c-]1ccccc1-c1ncc[n-]1.[c-]1ccccc1-n1cc(-c2ccc3c(c2)oc2ccccc23)cn1 |
| InChI | InChI=1S/2C23H20N2.C22H18N2.C21H13N2O.C10H5F3N2.2C10H8N2.C9H6N2.4Pt/c2*1-18-23(24(2)17-25(18)22-11-7-4-8-12-22)21-15-13-20(14-16-21)19-9-5-3-6-10-19;1-23-17-24(21-10-6-3-7-11-21)16-22(23)20-14-12-19(13-15-20)18-8-4-2-5-9-18;1-2-6-17(7-3-1)23-14-16(13-22-23)15-10-11-19-18-8-4-5-9-20(18)24-21(19)12-15;11-10(12,13)9-6-8(14-15-9)7-4-2-1-3-5-7;2*1-8-7-10(12-11-8)9-5-3-2-4-6-9;1-2-4-8(5-3-1)9-10-6-7-11-9;;;;/h2*3-11,13-17H,1-2H3;2-10,12-17H,1H3;1-6,8-14H;1-4,6H;2*2-5,7H,1H3;1-4,6-7H;;;;/q3*-2;-1;4*-2;;3*+4 |
| InChIKey | QKFKGWLRBZARCR-UHFFFAOYSA-N |
| XLogP | 28.74 |
| TPSA | 158.36 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 152 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2713.61 |
| LogP ≤ 5 | 28.74 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158024918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.